{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:59:15Z","timestamp":1790287155688,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82501249"],"award-info":[{"award-number":["82501249"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371035"],"award-info":[{"award-number":["82371035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2024C03206"],"award-info":[{"award-number":["2024C03206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtos.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:10:34Z","timestamp":1781050234000},"page":"163-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunomodulatory effects and clinical application of galectins in ocular surface"],"prefix":"10.1016","volume":"41","author":[{"given":"Xiaorui","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4040-6721","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2026.06.006_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fcell.2020.00253","article-title":"The emerging role of the mammalian glycocalyx in functional membrane organization and immune system regulation","volume":"8","author":"M\u00f6ckl","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jtos.2026.06.006_bib2","doi-asserted-by":"crossref","first-page":"15603","DOI":"10.1021\/acs.chemrev.1c01032","article-title":"Glycoconjugates: synthesis, functional studies, and therapeutic developments","volume":"122","author":"Shivatare","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.jtos.2026.06.006_bib3","doi-asserted-by":"crossref","first-page":"12764","DOI":"10.1016\/S0021-9258(18)31454-6","article-title":"Characterization of a specific ligand for P-selectin on myeloid cells. A minor glycoprotein with sialylated O-linked oligosaccharides","volume":"268","author":"Norgard","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2026.06.006_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-021-00713-x","article-title":"Intracellular galectins sense cytosolically exposed glycans as danger and mediate cellular responses","volume":"28","author":"Hong","year":"2021","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tibtech.2018.10.001","article-title":"Galectin-carbohydrate interactions in biomedicine and biotechnology","volume":"37","author":"Laaf","year":"2019","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jtos.2026.06.006_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.it.2013.01.006","article-title":"The regulatory power of glycans and their binding partners in immunity","volume":"34","author":"Johnson","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib7","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399408000719","article-title":"Galectins: structure, function and therapeutic potential","volume":"10","author":"Yang","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.jtos.2026.06.006_bib8","first-page":"599","article-title":"Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)","volume":"41","author":"Dong","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jtos.2026.06.006_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108120","article-title":"Galectins and their involvement in ocular disease and development","volume":"197","author":"Luis","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2026.06.006_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","article-title":"Targeting galectin-driven regulatory circuits in cancer and fibrosis","volume":"22","author":"Marino","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jtos.2026.06.006_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00417-012-2021-9","article-title":"Adhesion\/growth-regulatory galectins in the human eye: localization profiles and tissue reactivities as a standard to detect disease-associated alterations","volume":"250","author":"Schl\u00f6tzer-Schrehardt","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2026.06.006_bib12","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.08-2734","article-title":"Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling","volume":"50","author":"Mantelli","year":"2009","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib13","first-page":"2164","article-title":"Isolation and characterization of galectins in the mammalian retina","volume":"42","author":"Uehara","year":"2001","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib37","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.4049\/jimmunol.1103063","article-title":"Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions","volume":"188","author":"Rajasagi","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000882","article-title":"Galectin-9\/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response","volume":"6","author":"Sehrawat","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jtos.2026.06.006_bib60","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.4049\/jimmunol.0803673","article-title":"Role of Tim-3\/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators","volume":"182","author":"Sehrawat","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib36","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.4049\/jimmunol.1203501","article-title":"Galectin-1-mediated suppression of pseudomonas aeruginosa-induced corneal immunopathology","volume":"190","author":"Suryawanshi","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4049\/jimmunol.2200706","article-title":"Galectin-8 downmodulates TLR4 activation and impairs bacterial clearance in a mouse model of Pseudomonas aeruginosa Keratitis","volume":"210","author":"Ramadan","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107706","article-title":"Galectin-3 plays an important pro-inflammatory role in A. fumigatus keratitis by recruiting neutrophils and activating p38 in neutrophils","volume":"97","author":"Niu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jtos.2026.06.006_bib38","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1017\/S0031182017000270","article-title":"Galectins expressed differently in genetically susceptible C57BL\/6 and resistant BALB\/c mice during acute ocular infection","volume":"144","author":"Chen","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.jtos.2026.06.006_bib63","doi-asserted-by":"crossref","first-page":"23037","DOI":"10.1074\/jbc.M109.033332","article-title":"Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier","volume":"284","author":"Argueso","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2026.06.006_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000355846","article-title":"Galectin-3 enhances epithelial cell adhesion and wound healing in rat cornea","volume":"51","author":"Yabuta","year":"2014","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2026.06.006_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.exer.2015.06.010","article-title":"Galectin-3 enhances extracellular matrix associations and wound healing in monkey corneal epithelium","volume":"137","author":"Fujii","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2026.06.006_bib23","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1242\/jcs.045674","article-title":"Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin","volume":"122","author":"Saravanan","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archopht.121.1.82","article-title":"Galectin-7 as a potential mediator of corneal epithelial cell migration","volume":"121","author":"Cao","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2026.06.006_bib17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ajo.2015.02.008","article-title":"Alteration of galectin-3 in tears of patients with dry eye disease","volume":"159","author":"Uchino","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2026.06.006_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11010066","article-title":"Analysis of the association between Galectin-3 concentration in tears and the severity of dry eye disease: a case-control study","volume":"11","author":"Hata-Mizuno","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtos.2026.06.006_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw7095","article-title":"Galectin-3 initiates epithelial-stromal paracrine signaling to shape the proteolytic microenvironment during corneal repair","volume":"12","author":"AbuSamra","year":"2019","journal-title":"Sci Signal"},{"key":"10.1016\/j.jtos.2026.06.006_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exer.2017.03.006","article-title":"The analysis of human conjunctival epithelium proteome in ocular surface diseases using impression cytology and 2D-DIGE","volume":"167","author":"Soria","year":"2018","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2026.06.006_bib41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1167\/iovs.14-15100","article-title":"Immunomodulatory effects of galectin-1 on an IgE-mediated allergic conjunctivitis model","volume":"56","author":"Mello","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib65","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2018.05.046","article-title":"Treatment with galectin-1 eye drops regulates mast cell degranulation and attenuates the severity of conjunctivitis","volume":"833","author":"Mello-Bosnic","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jtos.2026.06.006_bib40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bjophthalmol-2017-311473","article-title":"Galectin-3: role in ocular allergy and potential as a predictive biomarker","volume":"102","author":"Andrade","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2026.06.006_bib66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000112501","article-title":"Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice","volume":"146","author":"Fukushima","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep17946","article-title":"Aflibercept traps Galectin-1, an angiogenic factor associated with diabetic retinopathy","volume":"5","author":"Kanda","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2026.06.006_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2017.02.015","article-title":"Silencing of galectin-1 inhibits retinal neovascularization and ameliorates retinal hypoxia in a murine model of oxygen-induced ischemic retinopathy","volume":"159","author":"Yang","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2026.06.006_bib55","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1096\/fj.201801227R","article-title":"Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition","volume":"33","author":"Wu","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.jtos.2026.06.006_bib59","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202403181R","article-title":"Stromal-like cells and retinal pigment epithelium modulate choroidal sprouting through Galectin-1-Dependent and independent pathways","volume":"39","author":"Ridano","year":"2025","journal-title":"FASEB J"},{"key":"10.1016\/j.jtos.2026.06.006_bib67","doi-asserted-by":"crossref","first-page":"29913","DOI":"10.1074\/jbc.M111.226423","article-title":"Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells","volume":"286","author":"Markowska","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2026.06.006_bib68","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1084\/jem.20090121","article-title":"Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response","volume":"207","author":"Markowska","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtos.2026.06.006_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05897-8","article-title":"Microglial Galectin3 enhances endothelial metabolism and promotes pathological angiogenesis via notch inhibition by competitively binding to Jag1","volume":"14","author":"Zhou","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtos.2026.06.006_bib69","first-page":"1036","article-title":"Protective effects of the galectin-1 protein on in vivo and in vitro models of ocular inflammation","volume":"21","author":"Zanon Cde","year":"2015","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2026.06.006_bib70","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.4049\/jimmunol.176.10.6323","article-title":"Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses","volume":"176","author":"Toscano","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130772","article-title":"Galectin-8 ameliorates murine autoimmune ocular pathology and promotes a regulatory T cell response","volume":"10","author":"Sampson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2026.06.006_bib72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/icb.2015.72","article-title":"Galectin-8 promotes regulatory T-cell differentiation by modulating IL-2 and TGF\u03b2 signaling","volume":"94","author":"Sampson","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jtos.2026.06.006_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2026.06.006_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajo.2025.05.033","article-title":"TFOS DEWS III: diagnostic methodology","volume":"279","author":"Wolffsohn","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2026.06.006_bib16","doi-asserted-by":"crossref","first-page":"23037","DOI":"10.1074\/jbc.M109.033332","article-title":"Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier","volume":"284","author":"Arg\u00fceso","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2026.06.006_bib20","article-title":"The ocular surface glycocalyx and its alteration in dry eye disease: a review","volume":"59","author":"Uchino","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib21","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.2147\/OPTH.S322079","article-title":"Corneal epithelial stem cell supernatant in the treatment of severe dry eye disease: a pilot study","volume":"15","author":"Rush","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2026.06.006_bib22","first-page":"89","article-title":"Role of galectins in re-epithelialization of wounds","volume":"2","author":"Panjwani","year":"2014","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jtos.2026.06.006_bib24","doi-asserted-by":"crossref","first-page":"42299","DOI":"10.1074\/jbc.M200981200","article-title":"Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds","volume":"277","author":"Cao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2026.06.006_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1167\/iovs.14-15338","article-title":"Fingerprinting of galectins in normal, P. Aeruginosa-infected, and chemically burned mouse corneas","volume":"56","author":"Chen","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib30","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1017\/S0031182017000270","article-title":"Galectins expressed differently in genetically susceptible C57BL\/6 and resistant BALB\/c mice during acute ocular Toxoplasma gondii infection","volume":"144","author":"Chen","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.jtos.2026.06.006_bib31","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/iai.65.7.2747-2753.1997","article-title":"Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins","volume":"65","author":"Gupta","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.jtos.2026.06.006_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052895","article-title":"Biophysical and structural characterization of the interaction between human Galectin-3 and the lipopolysaccharide from Pseudomonas aeruginosa","volume":"25","author":"Pirone","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib33","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1128\/JVI.00166-13","article-title":"Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes","volume":"87","author":"Woodward","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jtos.2026.06.006_bib35","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1167\/iovs.05-1234","article-title":"Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis","volume":"47","author":"Romero","year":"2006","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fmed.2017.00068","article-title":"Regulation of eosinophil recruitment and activation by galectins in allergic asthma","volume":"4","author":"Rao","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtos.2026.06.006_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100925","article-title":"Galectins in allergic inflammatory diseases","volume":"79","author":"Wan","year":"2021","journal-title":"Mol Aspect Med"},{"key":"10.1016\/j.jtos.2026.06.006_bib43","doi-asserted-by":"crossref","first-page":"32344","DOI":"10.1074\/jbc.M109.035196","article-title":"Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation","volume":"284","author":"Niki","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2026.06.006_bib44","first-page":"831","article-title":"expression of galectin-13 in allergic diseases involving airway, skin and mucous membranes","volume":"56","author":"Yi","year":"2022","journal-title":"Zhonghua Yufang Yixue Zazhi"},{"key":"10.1016\/j.jtos.2026.06.006_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2026.06.006_bib46","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.survophthal.2006.10.017","article-title":"Ocular neovascularization: basic mechanisms and therapeutic advances","volume":"52","author":"Dorrell","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2026.06.006_bib48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/aos.14191","article-title":"Galectin-1 studies in proliferative diabetic retinopathy","volume":"98","author":"Abu El-Asrar","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2026.06.006_bib49","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/glycob\/cwu078","article-title":"Glycobiology of ocular angiogenesis","volume":"24","author":"Markowska","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.jtos.2026.06.006_bib52","article-title":"Galectin-3 inhibition by A small-molecule inhibitor reduces both pathological corneal neovascularization and fibrosis","volume":"58","author":"Panjwani","year":"2017","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12112649","article-title":"Involvement of Lgals3\/Galectin-3 in choroidal neovascularization and subretinal fibrosis formation","volume":"12","author":"Wu","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtos.2026.06.006_bib54","article-title":"Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3 (vol 7, pg 11302, 2016)","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtos.2026.06.006_bib56","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ajpath.2023.11.018","article-title":"Anti-angiogenic and anti-scarring dual effect of Galectin-3 inhibition in mouse models of corneal wound healing","volume":"194","author":"Cao","year":"2024","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2026.06.006_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105479","article-title":"Available therapeutic options for corneal neovascularization: a review","volume":"25","author":"Drzyzga","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib58","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ajpath.2023.11.018","article-title":"Anti-angiogenic and anti-scarring dual effect of Galectin-3 inhibition in mouse models of corneal wound healing","volume":"194","author":"Cao","year":"2024","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2026.06.006_bib61","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1128\/JVI.01391-12","article-title":"TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions","volume":"86","author":"PB","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jtos.2026.06.006_bib74","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib75","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41423-023-01074-1","article-title":"Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection","volume":"20","author":"Pinho","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib76","first-page":"118","article-title":"Galectin-3 promotes noncanonical inflammasome activation through intracellular binding to lipopolysaccharide glycans","author":"Lo","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jtos.2026.06.006_bib77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2009.00790.x","article-title":"Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs)","volume":"230","author":"Sato","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jtos.2026.06.006_bib78","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nri2536","article-title":"Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation","volume":"9","author":"Rabinovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib79","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2011.06386.x","article-title":"Galectins in acute and chronic inflammation","volume":"1253","author":"Liu","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jtos.2026.06.006_bib80","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1073\/pnas.1922778117","article-title":"Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits","volume":"117","author":"Martinez","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2026.06.006_bib81","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/glycob\/cwn104","article-title":"Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils","volume":"19","author":"Karlsson","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.jtos.2026.06.006_bib82","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12974-022-02589-6","article-title":"Genetic targeting or pharmacological inhibition of galectin-3 dampens microglia reactivity and delays retinal degeneration","volume":"19","author":"Tabel","year":"2022","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jtos.2026.06.006_bib83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.immuni.2012.05.023","article-title":"Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration","volume":"37","author":"Starossom","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jtos.2026.06.006_bib84","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","article-title":"Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells","volume":"116","author":"Gieseke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtos.2026.06.006_bib85","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.190.3.385","article-title":"Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis","volume":"190","author":"Rabinovich","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtos.2026.06.006_bib86","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cei\/uxad131","article-title":"Galectin-1 correlates with inflammatory markers and T regulatory cells in children with type 1 diabetes and\/or celiac disease","volume":"215","author":"Fryk","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib87","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clim.2011.09.011","article-title":"Galectin-1 research in T cell immunity: past, present and future","volume":"142","author":"Cedeno-Laurent","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib88","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibrian","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib89","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s11626-012-9540-x","article-title":"Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells","volume":"48","author":"Dabelic","year":"2012","journal-title":"In Vitro Anim Cell Dev Biol"},{"key":"10.1016\/j.jtos.2026.06.006_bib90","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cellbi.2005.12.010","article-title":"Interaction of human neutrophils with endothelial cells regulates the expression of endogenous proteins annexin 1, galectin-1 and galectin-3","volume":"30","author":"Gil","year":"2006","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jtos.2026.06.006_bib91","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10384-023-00994-9","article-title":"Galectin-3, a damage-associated molecular pattern, in tears of patients with vernal keratoconjunctivitis","volume":"67","author":"Ito","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jtos.2026.06.006_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107933","article-title":"TIM-3: an update on immunotherapy","volume":"99","author":"Zhao","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jtos.2026.06.006_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063620","article-title":"Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts","volume":"8","author":"Shimmura-Tomita","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2026.06.006_bib73","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bbrc.2017.07.144","article-title":"Tim3\/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt\/NF-kB signaling pathway","volume":"491","author":"Luo","year":"2017","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.jtos.2026.06.006_bib94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","article-title":"Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis","volume":"127","author":"Seki","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68401-y","article-title":"Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis","volume":"14","author":"Quinn","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2026.06.006_bib96","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1111\/all.16239","article-title":"In chronic spontaneous urticaria, increased Galectin-9 expression on basophils and eosinophils is linked to high disease activity, endotype-specific markers, and response to omalizumab treatment","volume":"79","author":"Ji","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jtos.2026.06.006_bib97","article-title":"Galectin-9 as an indicator of functional limitations and radiographic joint damage in patients with rheumatoid arthritis","volume":"15","author":"Guo","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib98","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.3389\/fimmu.2018.02839","article-title":"Galectin-Glycan interactions as regulators of B cell immunity","volume":"9","author":"Giovannone","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib99","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/s41467-018-04063-5","article-title":"Galectin-3 deficiency drives lupus-like disease by promoting spontaneous germinal centers formation via IFN-\u03b3","volume":"9","author":"Beccaria","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtos.2026.06.006_bib100","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ajpath.2018.01.017","article-title":"Galectin-9 is critical for mucosal adaptive immunity through the T helper 17-IgA axis","volume":"188","author":"Liang","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2026.06.006_bib101","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4049\/jimmunol.1100297","article-title":"Galectin-1 and galectin-8 have redundant roles in promoting plasma cell formation","volume":"187","author":"Tsai","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib102","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/leu.2015.39","article-title":"Chlamydophila psittaci-negative ocular adnexal marginal zone lymphomas express self polyreactive B-cell receptors","volume":"29","author":"Zhu","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jtos.2026.06.006_bib103","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","article-title":"TFOS DEWS II sex, gender, and hormones report","volume":"15","author":"Sullivan","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2026.06.006_bib104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1126\/science.ado8542","article-title":"Sex differences in tissue immunity","volume":"384","author":"Puttur","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jtos.2026.06.006_bib105","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","article-title":"Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death","volume":"8","author":"Toscano","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib106","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00281-024-01032-7","article-title":"Galectin-1 and galectin-3 in male reproduction - impact in health and disease","volume":"47","author":"Fijak","year":"2025","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jtos.2026.06.006_bib107","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13293-023-00556-1","article-title":"Sex-specific role of galectin-3 in aortic stenosis","volume":"14","author":"Matilla","year":"2023","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.jtos.2026.06.006_bib108","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301832RR","article-title":"Sex-dependent expression of galectin-1, a cardioprotective beta-galactoside-binding lectin, in human calcific aortic stenosis","volume":"38","author":"Jover","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.jtos.2026.06.006_bib109","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1471-4906(02)02232-9","article-title":"Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?","volume":"23","author":"Rabinovich","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jtos.2026.06.006_bib110","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtos.2026.06.006_bib111","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","article-title":"Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells","volume":"41","author":"Wu","year":"2014","journal-title":"Immunity"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012426000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012426000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:04:38Z","timestamp":1790283878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012426000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":111,"alternative-id":["S1542012426000728"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2026.06.006","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory effects and clinical application of galectins in ocular surface","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}